Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
Background. Nonalcoholic fatty liver disease (NAFLD) is a rising indication for liver transplantation (LT). Identification of NAFLD recurrence and those at risk for more progressive disease after LT remains elusive as the diagnosis requires biopsy, which is invasive and impractical for serial monito...
Saved in:
Main Authors: | Christopher J. Mowry, MD, Cristina Alonso, PhD, Marta Iruarrizaga-Lejarreta, PhD, Pablo Ortiz, MD, PhD, Josh Levitsky, MD, MS, Mary Rinella, MD |
---|---|
Format: | article |
Language: | EN |
Published: |
Wolters Kluwer
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7d381d77ca3448e398a9f05fef8fee10 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ischaemia-free liver transplantation in humans: a first-in-human trial
by: Zhiyong Guo, M.D., Ph.D., et al.
Published: (2021) -
Discordance Between SARS-CoV-2–specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients
by: Mario Fernández-Ruiz, MD, PhD, et al.
Published: (2021) -
Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients
by: Filippo Massa, PhD, et al.
Published: (2021) -
SARS-CoV-2–specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19
by: Dominique Bertrand, MD, et al.
Published: (2021) -
Dual Lactate Clearance in the Viability Assessment of Livers Donated After Circulatory Death With Ex Situ Normothermic Machine Perfusion
by: Min Xu, MD, et al.
Published: (2021)